Literature DB >> 14605052

Spirometric reference values for the 6-s FVC maneuver.

John L Hankinson1, Robert O Crapo, Robert L Jensen.   

Abstract

STUDY
OBJECTIVES: The guidelines of the National Lung Health Education Program for COPD screening proposed a shorter FVC maneuver (forced expiratory volume at 6 s of exhalation [FEV(6)]). Although reference values for FEV(6) are available from the third National Health and Nutrition Examination Survey, forced expiratory flow between 25% and 75% of FVC (FEF(25-75%)) reference values for the shorter 6-s maneuver are not available and are needed. In particular, calculation of largest observed volume during the first 6 s of an FVC maneuver (FVC(6)), from a shortened FVC maneuver, is necessary because the FEF(25-75%) measurement is based on a percentage of FVC or, for a shorter maneuver, FVC(6).
DESIGN: We reanalyzed the raw volume-time curves from the third National Health and Nutrition Examination Survey to calculate FVC(6), forced expiratory volume at 0.5 s of exhalation, forced expiratory volume at 3 s of exhalation, ratio of the FEV(1) to largest observed volume during the first 6 s of an FVC maneuver expressed as a percentage (FEV(1)/FEV(6)%), and forced expiratory flow between 25% and 75% of the largest observed volume during the first 6 s of an FVC maneuver (FEF(25-75%6)) in addition to the previously reported values for FEV(1), FEV(6), and FEV(1)/FEV(6)%. PATIENTS OR PARTICIPANTS: Using the same normal, asymptomatic, nonsmoking reference population from a previous study, reference values for these parameters were derived from best values.
RESULTS: A total of 2,261 white, 2,564 African-American, and 2,666 Mexican-American subjects aged 8 to 80 years were included in the analysis. Fifty-four subjects from the previous study were not included due to missing raw volume-time curves.
CONCLUSIONS: These reference values, utilizing the FVC(6), provide investigators with the means of evaluating the relative merits of using the shorter FVC maneuver as a surrogate for the traditional FVC. They are needed particularly for calculating FEF(25-75%), as statistically significant differences were observed between the FEF(25-75%) and FEF(25-75%6).

Entities:  

Mesh:

Year:  2003        PMID: 14605052     DOI: 10.1378/chest.124.5.1805

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  18 in total

1.  FEV(1)/FEV(6) to diagnose airflow obstruction. Comparisons with computed tomography and morbidity indices.

Authors:  Surya P Bhatt; Young-Il Kim; James M Wells; William C Bailey; Joe W Ramsdell; Marilyn G Foreman; Robert L Jensen; Douglas S Stinson; Carla G Wilson; David A Lynch; Barry J Make; Mark T Dransfield
Journal:  Ann Am Thorac Soc       Date:  2014-03

2.  On-site screening of farming-induced chronic obstructive pulmonary disease with the use of an electronic mini-spirometer: results of a pilot study in Brittany, France.

Authors:  Stephane Jouneau; Arnaud Boché; Graziella Brinchault; Kristina Fekete; Stephanie Guillot; Sahar Bayat; Benoit Desrues
Journal:  Int Arch Occup Environ Health       Date:  2011-10-11       Impact factor: 3.015

3.  Re-Defining Lower Limit of Normal for FEV1/FEV6, FEV1/FVC, FEV3/FEV6 and FEV3/FVC to Improve Detection of Airway Obstruction.

Authors:  James E Hansen; Janos Porszasz; Richard Casaburi; William W Stringer
Journal:  Chronic Obstr Pulm Dis       Date:  2015-03-10

4.  A randomized controlled trial to evaluate inhibition of T-cell costimulation in allergen-induced airway inflammation.

Authors:  Amit D Parulekar; Jonathan S Boomer; Brenda M Patterson; Huiqing Yin-Declue; Christine M Deppong; Brad S Wilson; Nizar N Jarjour; Mario Castro; Jonathan M Green
Journal:  Am J Respir Crit Care Med       Date:  2013-01-04       Impact factor: 21.405

5.  Lung VITAL: Rationale, design, and baseline characteristics of an ancillary study evaluating the effects of vitamin D and/or marine omega-3 fatty acid supplements on acute exacerbations of chronic respiratory disease, asthma control, pneumonia and lung function in adults.

Authors:  Diane R Gold; Augusto A Litonjua; Vincent J Carey; JoAnn E Manson; Julie E Buring; I-Min Lee; David Gordon; Joseph Walter; Georgina Friedenberg; John L Hankinson; Trisha Copeland; Heike Luttmann-Gibson
Journal:  Contemp Clin Trials       Date:  2016-01-16       Impact factor: 2.226

6.  A Novel Spirometric Measure Identifies Mild COPD Unidentified by Standard Criteria.

Authors:  Asli Gorek Dilektasli; Janos Porszasz; Richard Casaburi; William W Stringer; Surya P Bhatt; Youngju Pak; Harry B Rossiter; George Washko; Peter J Castaldi; Raul San Jose Estepar; James E Hansen
Journal:  Chest       Date:  2016-07-22       Impact factor: 9.410

7.  FEV1 as a Standalone Spirometric Predictor and the Attributable Fraction for Death in Older Persons.

Authors:  Carlos A Vaz Fragoso; Peter H Van Ness; Gail J McAvay
Journal:  Respir Care       Date:  2019-10-29       Impact factor: 2.258

8.  Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function.

Authors:  María Soler Artigas; Louise V Wain; Emmanouela Repapi; Ma'en Obeidat; Ian Sayers; Paul R Burton; Toby Johnson; Jing Hua Zhao; Eva Albrecht; Anna F Dominiczak; Shona M Kerr; Blair H Smith; Gemma Cadby; Jennie Hui; Lyle J Palmer; Aroon D Hingorani; S Goya Wannamethee; Peter H Whincup; Shah Ebrahim; George Davey Smith; Inês Barroso; Ruth J F Loos; Nicholas J Wareham; Cyrus Cooper; Elaine Dennison; Seif O Shaheen; Jason Z Liu; Jonathan Marchini; Santosh Dahgam; Asa Torinsson Naluai; Anna-Carin Olin; Stefan Karrasch; Joachim Heinrich; Holger Schulz; Tricia M McKeever; Ian D Pavord; Markku Heliövaara; Samuli Ripatti; Ida Surakka; John D Blakey; Mika Kähönen; John R Britton; Fredrik Nyberg; John W Holloway; Debbie A Lawlor; Richard W Morris; Alan L James; Cathy M Jackson; Ian P Hall; Martin D Tobin
Journal:  Am J Respir Crit Care Med       Date:  2011-10-01       Impact factor: 21.405

9.  Responses of FEV6, FVC, and FET to inhaled bronchodilator in the adult general population.

Authors:  Annette Kainu; Ari Lindqvist; Seppo Sarna; Bo Lundbäck; Anssi Sovijärvi
Journal:  Respir Res       Date:  2009-07-28

10.  Reliability of FEV1/FEV6 to diagnose airflow obstruction compared with FEV1/FVC: the PLATINO longitudinal study.

Authors:  Rogelio Perez-Padilla; Fernando C Wehrmeister; Bartolome R Celli; Maria Victorina Lopez-Varela; Maria Montes de Oca; Adriana Muiño; Carlos Talamo; Jose R Jardim; Gonzalo Valdivia; Carmen Lisboa; Ana Maria B Menezes
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.